EBR Systems Targets $3.6 Billion Market on Commercial Launch, Shares Slump 12%

MT Newswires Live

May 22, 2025

EBR Systems (ASX:EBR) is targeting an around $3.6 billion initial addressable market at the commercial launch of its Wireless Stimulation Endocardially (WiSE) Cardiac Resynchronisation Therapy (CRT) system, according to a Thursday Australian bourse filing.

The firm submitted its application to the US Centers for Medicare & Medicaid Services for the transitional pass-through reimbursement scheme for its proprietary WiSE CRT system.

The biggest segment in the initial addressable market is expected to be patients for whom the traditional CRT system implant has ceased to provide effective CRT. This segment represents $1.45 billion.

High-risk patients and patients with a leadless right ventricle pacemaker are also part of the firm's initial addressable market. Medtronic's Micra leadless pacemaker has been qualified for use with the WiSE CRT system.

The firm's shares slumped 12% in recent trading on Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2537993213"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537993213\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537993213?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 13:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537993213","market":"hk","top_or_hot":-1,"title":"EBR Systems Targets $3.6 Billion Market on Commercial Launch, Shares Slump 12%","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) is targeting an around $3.6 billion initial addressable market at the commercial launch of its Wireless Stimulation Endocardially (WiSE) Cardiac Resynchronisation Therapy (CRT) system, according to a Thursday Australian bourse filing.</p><p>The firm submitted its application to the US Centers for Medicare &amp; Medicaid Services for the transitional pass-through reimbursement scheme for its proprietary WiSE CRT system.</p><p>The biggest segment in the initial addressable market is expected to be patients for whom the traditional CRT system implant has ceased to provide effective CRT. This segment represents $1.45 billion.</p><p>High-risk patients and patients with a leadless right ventricle pacemaker are also part of the firm's initial addressable market. Medtronic's Micra leadless pacemaker has been qualified for use with the WiSE CRT system.</p><p>The firm's shares slumped 12% in recent trading on Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Systems Targets $3.6 Billion Market on Commercial Launch, Shares Slump 12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Systems Targets $3.6 Billion Market on Commercial Launch, Shares Slump 12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-22 13:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) is targeting an around $3.6 billion initial addressable market at the commercial launch of its Wireless Stimulation Endocardially (WiSE) Cardiac Resynchronisation Therapy (CRT) system, according to a Thursday Australian bourse filing.</p><p>The firm submitted its application to the US Centers for Medicare &amp; Medicaid Services for the transitional pass-through reimbursement scheme for its proprietary WiSE CRT system.</p><p>The biggest segment in the initial addressable market is expected to be patients for whom the traditional CRT system implant has ceased to provide effective CRT. This segment represents $1.45 billion.</p><p>High-risk patients and patients with a leadless right ventricle pacemaker are also part of the firm's initial addressable market. Medtronic's Micra leadless pacemaker has been qualified for use with the WiSE CRT system.</p><p>The firm's shares slumped 12% in recent trading on Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRT","symbol_name":"CRT信托","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2537993213","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537993213","pubTimestamp":1747891015,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems  is targeting an around $3.6 billion initial addressable market at the commercial launch of its Wireless Stimulation Endocardially  Cardiac Resynchronisation Therapy  system, according to a Thursday Australian bourse filing.The firm submitted its application to the US Centers for Medicare & Medicaid Services for the transitional pass-through reimbursement scheme for its proprietary WiSE CRT system.The biggest segment in the initial addressable market is expected to be patients for whom the traditional CRT system implant has ceased to provide effective CRT. This segment represents $1.45 billion.High-risk patients and patients with a leadless right ventricle pacemaker are also part of the firm's initial addressable market. Medtronic's Micra leadless pacemaker has been qualified for use with the WiSE CRT system.The firm's shares slumped 12% in recent trading on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRT":"CRT信托","BK4213":"石油与天然气的勘探与生产","BK7007":"医疗保健设备","IE00B1B80R65.USD":"柏瑞拉丁美洲股票A","BK4081":"电力公用事业","EBR.AU":"EBR SYSTEMS INC-CDI"},"translate_title":"EBR Systems商业上市目标市场价值36亿美元，股价暴跌12%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR":1,"EBR.AU":0.9,"CRT":1},"content_text":"EBR Systems (ASX:EBR) is targeting an around $3.6 billion initial addressable market at the commercial launch of its Wireless Stimulation Endocardially (WiSE) Cardiac Resynchronisation Therapy (CRT) system, according to a Thursday Australian bourse filing.The firm submitted its application to the US Centers for Medicare & Medicaid Services for the transitional pass-through reimbursement scheme for its proprietary WiSE CRT system.The biggest segment in the initial addressable market is expected to be patients for whom the traditional CRT system implant has ceased to provide effective CRT. This segment represents $1.45 billion.High-risk patients and patients with a leadless right ventricle pacemaker are also part of the firm's initial addressable market. Medtronic's Micra leadless pacemaker has been qualified for use with the WiSE CRT system.The firm's shares slumped 12% in recent trading on Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}